ALKERMES | ALKS - Eps Utile Per Azione

Prezzo Delle Azioni
27.76
Cambio Giornaliero
0.12 0.43%
Mensile
-15.62%
Annuale
-18.42%
Q1 Previsione
26.93

Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q1 Mar/2026 -0.4 0.13 Apr/29 2026
FY2025Q4 Dec/2025 0.29 0.42 1.05 Feb/25 2026
FY2025Q3 Sep/2025 0.49 0.4 0.73 Oct/28 2025
FY2025Q2 Jun/2025 0.52 0.39 0.72 Jul/29 2025
FY2025Q1 Mar/2025 0.13 0.39 0.43 May/01 2025




Eps Cambiamento Data
AbbVie USD 2.71 0.85 2025-12
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
ALKERMES USD 0.29 0.2 2025-12
Amgen USD 5.29 0.35 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Coherus Biosciences USD -0.35 0.07 2025-03
Eli Lilly USD 7.54 0.52 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Heron Therapeutics USD -0.03 0.03 2024-09
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
J&J USD 2.46 0.34 2025-12
Malin Corporation EUR -0.06 0.1 2023-12
Merck USD 2.04 0.54 2025-12
Minerva Neurosciences USD -0.56 3.53 2024-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 1.88 0.29 2025-12
Otsuka Holdings JPY 124.25 110.44 2025-12
Ovoca Bio EUR -0.07 0.04 2022-06
Pfizer USD 0.66 0.21 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12